Fischer Medical Ventures and BluSim Tech forge strategic partnership

The partnership aim to redefine elderly care globally

Fischer Medical Ventures (formerly known as Fischer Chemic) with its wholly owned subsidiary – Ms. Time Medical International Ventures (India), and BluSim Tech,have announced a partnership aimed at revolutionising nursing home care globally.

Fischer Medical Ventures  (Fischer MVL), known to be the first company through its wholly owned subsidiary Time Medical International Ventures (India) to indigenously manufacture advanced high quality, cost-efficient Magnetic Resonance Imaging (MRI) systems in India, continues to spearhead innovation in the MedTech industry. 

Apart from medical imaging, Fischer MVL strategically invests into a portfolio of high-tech diagnostic solutions. This strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL’s journey towards expanding its healthcare portfolio and enhancing its offerings in medical imaging and diagnostics solutions, aiming to redefine healthcare through advanced technologies and unparalleled expertise.

BluSim Tech  is a health-tech company based in Singapore, dedicated to transforming the elder care industry. Their technology, Ballistocardiography, is a non-invasive method based on the measurement of the body motion generated by the ejection of the blood at each cardiac cycle. Their product, BluSim Mat, powered by advanced algorithms and AI, enables continuous and contactless vital monitoring, including heart rate, respiration rate, sleep pattern, bed position, and presence monitoring, all without wearable devices.

By converting micro vibrations into meaningful biomarkers, BluSim Tech’s solution provides real-time monitoring of patient vitals and detect early warning for potential health issues. 

According to the WHO, the senior population in emerging nations is expected to reach about 1 billion by 2050, resulting in a high demand for elder care services. The global long term elder care market size was accounted for at US$1.03 trillion in 2022 and is projected to reach over US$1.92 trillion by 2032 (1). 

Global market is facing significant challenges posed by an aging population, creating a big demand for continuous, non-intrusive health monitoring to manage chronic conditions and age-related health issues. This growing market encompasses nursing homes, hospitals, and home care environments, offering significant opportunities for BluSim Tech to provide their real-time health monitoring solutions that improve patient outcomes and reduce healthcare costs.

References:\

1. (source: www.precedenceresearch.com)